Inflammatory diseases


SPMs and infection

  • 11/02/2017

Current strategies in treating infection aim to reduce inflammation by using proinflammatory molecule inhibitors and/or by inhibiting bacterial proliferation using antibiotics.

Read more



Omega-3 PUFA and SPM in critical patients

  • 09/08/2017

The prognosis of critical patients is closely related to their inflammatory status and the extent and duration of the inflammatory response.

Read more



Resolvins, inflammation and cancer

  • 09/21/2016

Inflammation, involved not just in inflammatory diseases (such as gastroenteritis or hepatitis) but also in the pathogenesis of obesity, diabetes and neurological diseases, contributes to the genesis and progression of cancer.

Read more



Supplementation with omega-3 fatty acids lengthens DNA telomeres and reduces inflammation

  • 06/10/2013

Observational studies have associated low plasma levels of omega-3 polyunsaturated fatty acids (PUFAs) with an increase in inflammation and depressive states.

Read more